Search research articles
Contact Us
Filters
Showing results (121-130 of 145) with videos related to
Page
of 15
Sort By:
Anti-Cancer Drug Design
|
January 1, 1997
Toxicological properties of several novel oligonucleotide analogs in mice
S P Henry, J E Zuckerman, J Rojko, et al.
The American Journal of Physiology
|
September 1, 1988
Metabolic changes in skeletal muscle and blood of greyhounds during 800-m track sprint
G P Dobson, W S Parkhouse, J M Weber, et al.
The Journal of Pharmacy and Pharmacology
|
July 1, 1987
Studies on the mechanisms of action of activated charcoal on theophylline pharmacokinetics
R S Mckinnon, P V Desmond, P J Harman, et al.
Journal of Food Protection
|
November 29, 2015
Physiological and Molecular Characterization of Salmonella Bacteriophages Previously Used in Phage Therapy
J Zhang, Y Hong, M Fealey, et al.
Theriogenology
|
February 1, 1991
Effect of gonadotropin-releasing hormone on fertility in repeat-breeder California dairy cows
R H Bondurant, I Revah, C Franti, et al.
The New Zealand Medical Journal
|
April 13, 1994
Mammography for younger women
I Campbell, C Dowle, J Harman, et al.
European Journal of Clinical Pharmacology
|
January 1, 1986
The effects of age and chronic liver disease on the elimination of temazepam
H Ghabrial, P V Desmond, K J Watson, et al.
Alimentary Pharmacology & Therapeutics
|
December 7, 2017
Obesity and type 2 diabetes are important risk factors underlying previously undiagnosed cirrhosis in general practice: a cross-sectional study using transient elastography
D J Harman, S D Ryder, M W James, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
December 4, 2023
The association of environmental factors with neurocognitive outcomes in survivors of childhood acute lymphoblastic leukemia (ALL)
S E Nigro, L P Hall, J Harman, et al.
BMJ Open
|
July 7, 2017
Economic evaluation of a community-based diagnostic pathway to stratify adults for non-alcoholic fatty liver disease: a Markov model informed by a feasibility study
Lukasz Tanajewski, Rebecca Harris, David J Harman, et al.
Page
of 15
Search research articles
Search
Showing results (121-130 of 145) with videos related to
Sort By:
Page
of 15
Anti-Cancer Drug Design
|
January 1, 1997
Toxicological properties of several novel oligonucleotide analogs in mice
S P Henry, J E Zuckerman, J Rojko, et al.
The American Journal of Physiology
|
September 1, 1988
Metabolic changes in skeletal muscle and blood of greyhounds during 800-m track sprint
G P Dobson, W S Parkhouse, J M Weber, et al.
The Journal of Pharmacy and Pharmacology
|
July 1, 1987
Studies on the mechanisms of action of activated charcoal on theophylline pharmacokinetics
R S Mckinnon, P V Desmond, P J Harman, et al.
Journal of Food Protection
|
November 29, 2015
Physiological and Molecular Characterization of Salmonella Bacteriophages Previously Used in Phage Therapy
J Zhang, Y Hong, M Fealey, et al.
Theriogenology
|
February 1, 1991
Effect of gonadotropin-releasing hormone on fertility in repeat-breeder California dairy cows
R H Bondurant, I Revah, C Franti, et al.
The New Zealand Medical Journal
|
April 13, 1994
Mammography for younger women
I Campbell, C Dowle, J Harman, et al.
European Journal of Clinical Pharmacology
|
January 1, 1986
The effects of age and chronic liver disease on the elimination of temazepam
H Ghabrial, P V Desmond, K J Watson, et al.
Alimentary Pharmacology & Therapeutics
|
December 7, 2017
Obesity and type 2 diabetes are important risk factors underlying previously undiagnosed cirrhosis in general practice: a cross-sectional study using transient elastography
D J Harman, S D Ryder, M W James, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
December 4, 2023
The association of environmental factors with neurocognitive outcomes in survivors of childhood acute lymphoblastic leukemia (ALL)
S E Nigro, L P Hall, J Harman, et al.
BMJ Open
|
July 7, 2017
Economic evaluation of a community-based diagnostic pathway to stratify adults for non-alcoholic fatty liver disease: a Markov model informed by a feasibility study
Lukasz Tanajewski, Rebecca Harris, David J Harman, et al.
Page
of 15